• Home
  • News
    • USA News
    • USA Celebrities
    • UK Celebrities News
    • Entertainment
  • WatchMoviesOnline
    • Bollywood Hindi Movies
  • Pakistani Drama
    • Hum TV Drama
  • Funny Videos
  • Technoloy
  • Contact us
    • Privacy Policy
    • Advertise with us
    • About us
    • Disclaimer
    • Contact us
Wirewag
  • Home
  • News
    • USA News
    • USA Celebrities
    • UK Celebrities News
    • Entertainment
  • WatchMoviesOnline
    • Bollywood Hindi Movies
  • Pakistani Drama
    • Hum TV Drama
  • Funny Videos
  • Technoloy
  • Contact us
    • Privacy Policy
    • Advertise with us
    • About us
    • Disclaimer
    • Contact us
No Result
View All Result
  • Home
  • News
    • USA News
    • USA Celebrities
    • UK Celebrities News
    • Entertainment
  • WatchMoviesOnline
    • Bollywood Hindi Movies
  • Pakistani Drama
    • Hum TV Drama
  • Funny Videos
  • Technoloy
  • Contact us
    • Privacy Policy
    • Advertise with us
    • About us
    • Disclaimer
    • Contact us
No Result
View All Result
Wirewag
No Result
View All Result
Home World News

The first drug to treat corona in the world enters the clinical trial stage

by admin
September 7, 2021
in World News
0
The first drug to treat corona in the world enters the clinical trial stage
Spread the love

In early April, the Russian Ministry of Health recorded the world’s first distinct immunoglobulin for the Corona virus on the basis of the blood plasma of people recovering from the disease

The Russian Federal Biomedical Agency announced that the drug “Covid globulin”, the first registered immune drug in the world, is currently undergoing clinical trials.

“The first phase of clinical trials of a drug prepared in the laboratory of the Rostec Corporation Immuno-Natsymbio Corporation, which is a unique anti-Covid immunoglobulin, is taking place,” Olga Eichler, head of the medical support department at the Russian Federal Biomedical Agency, said in a statement on the sidelines of the East Economic Forum. , according to Russian media.

In early April, the Russian Ministry of Health recorded the world’s first distinct immunoglobulin for the Corona virus, based on the blood plasma of people recovering from the disease.

After the completion of the second and third phases of clinical trials, it is expected that the drug will be used in the treatment of moderate and severe cases of Covid-19 infection.

The Corona virus has caused the death of at least 4,565,622 people in the world since the World Health Organization office in China reported the emergence of the disease at the end of December 2019.

At least 220,652,860 people have been confirmed to have contracted the virus since its appearance. The vast majority of those infected recovered, although some continued to experience symptoms weeks or even months later.

The figures are based on daily reports issued by each country’s health authorities and exclude subsequent reviews by statistical agencies that indicate much higher death numbers.

The World Health Organization, taking into account the excess mortality rate directly or indirectly related to Covid-19, considers that the outcome of the epidemic may be two or three times greater than the officially announced outcome.

Previous Post

Elon Musk says his satellite Internet service will be 40% faster than fiber optics

Next Post

Biden: There is still a long way to go to recognize the Taliban

Next Post
Biden: There is still a long way to go to recognize the Taliban

Biden: There is still a long way to go to recognize the Taliban

Please login to join discussion




ADVERTISEMENT
  • About us
  • Advertise with us
  • Contact us

© 2023 JNews - Premium WordPress news & magazine theme by Jegtheme.

No Result
View All Result
  • About Kashmir
  • About us
  • Advertise with us
  • Board Members
  • Contact us
  • Disclaimer
  • Home
  • Jennifer Lawrence Wrote a letter on Hollywood wage gap
  • Jhok Sarkar
  • Photo Gallery
  • Privacy Policy
  • WatchMoviesOnline
  • Wirewag

© 2023 JNews - Premium WordPress news & magazine theme by Jegtheme.